mRNA vaccine candidates for HIV enter Phase I trial - Will mRNA vaccines one day protect against HIV? Three investigational mRNA vaccines, all designed to combat HIV, have entered Phase I testing

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), has begun a Phase I trial evaluating three experimental messenger RNA (mRNA) HIV vaccines. These vaccines are based on the same technology as the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna.

More details at the following link: https://www.europeanpharmaceuticalreview.com/news/169298/mrna-vaccine-candidates-for-hiv-enter-phase-i-trial/